Price per Dose: £105 for BCG AJV, which is made in Denmark and is the only BCG vaccine licensed in the UK. For more details, please refer to the official product insert information. here

Number of Doses for the Primary Course: 1
Minimum Dose Intervals: –
Age Eligibility: Birth onwards*
Booster Dose Requirement: None required

BCG can be administered at any time before or after other vaccines:

Children born on or after September 1, 2021, are required to present confirmation of a negative newborn heel prick test result, also known as newborn blood spot screening. If the child was not offered this screening, that confirmation must also be provided before we can administer the BCG vaccine.

Parents must bring their child's Red Book along with the letter containing the outcome of the newborn’s blood spot screening to their appointment. Vaccination may be given earlier than 28 days if a heel prick test result is available, along with proof of that result.

Price per dose: £85

Number of Doses for Primary Course: 1
Minimum Dose Intervals: –
Age: Birth onwards
Booster Dose Requirement:: n/a

Price per dose: £40

Please bring a form of photographic identification (e.g., driving license or passport) at your appointment.

A certificate will be provided.

Price per dose: £75
Number of doses for the primary course: 2
Minimum dose intervals: 3 months for 9-12 months of age & 1 year+ 4 weeks
Age: 9 month+
When a booster dose is given (in years): None required

Giving Chickenpox (varicella) and MMR vaccines:

Price for the Full Course: £80
Age: 2+
When a booster dose is given (in years): 2 years for 6 years+ & 6 months for 2-6 years of age

Can this vaccine protect against travellers' diarrhoea?

In clinical trials, cholera vaccine has shown efficacy in protecting against infection by ETEC (Enterotoxigenic Escherichia coli), a common cause of travellers’ diarrhoea.
However, it is important to note that the vaccine is not licensed in the UK for protecting against either ETEC infection or travellers’ diarrhoea (it is only licensed for cholera); this vaccine may be considered for travellers’ diarrhoea for

1. Travellers for whom even a brief episode of diarrhoea could be consequential (e.g. other underlying medical condition).
2. Travellers prone to severe diarrhoea.

Price per dose: £42
Number of doses for the primary course: 1
Minimum dose intervals: –
Age: 6+
When a booster dose is given (in years): 10

This is a 3-in-1 vaccine called Revaxis, used for travel & tetanus vaccinations after an accident or injury.

Why do we give tetanus boosters to travelers when only five doses of the vaccine are needed for life in the UK, without additional boosters?

It is true that only five doses of the tetanus vaccine are required for life in the UK. However, this is based on the assumption that individuals would have easy access to the appropriate treatment, such as a tetanus booster or immunoglobulin, in case of a tetanus-prone wound.

We provide tetanus boosters to travelers when we cannot guarantee that they will have quick access to adequate medical care. This is especially important in countries where medical facilities and supplies are limited, as obtaining tetanus immunoglobulin may be challenging. To avoid this risk, we administer additional vaccine doses before their departure.

Price per dose: £114
Number of doses for the primary course: 2
Minimum dose intervals: 0 & 6-12 months 
Age: 1-15
When a booster dose is given (in years): Refer to individual vaccines for specifics

This vaccine's brand name is Ambirix and it would simplify long-term protection from both infections with only two doses, 6 months apart. 

Paid-for COVID-19 vaccination for all individuals 12 years of age and over (2024-25):

We offer Comirnaty JN.1 30 micrograms/dose - i.e. the Pfizer 'updated' COVID-19 mRNA vaccine.

Price per dose: £92
Number of doses for primary course: 1
Age: 12+
When a booster dose given (in years): Annual 

See the official insert of this vaccine here

To book an appointment for the private COVID-19 vaccination, please call 020 7435 7075

Price per dose: £119
Number of doses for the primary course: 2
Minimum dose intervals: 3 months (majority of protection comes from the 1st dose)
Age: 4+
When a booster dose given (in years): Not yet established - should be effective for at least around 5 years after 2 doses

Information on dengue

When compared to other diseases that travellers are regularly vaccinated against, there may be a higher risk of contracting dengue.  See Incidence rate per month of vaccine-preventable diseases in travellers; best estimate for non-immunes - Journal of Travel Medicine, taad085, https://doi.org/10.1093/jtm/taad085 June 2023

The burden of dengue has become heavier dramatically in the past 30 years and it occurs mostly in urban and semi-urban areas.

Travellers who spend long periods in endemic areas are at increased risk. However, even short-term visitors may be exposed.

The risk for severe dengue is greater during a second dengue infection; although severe dengue also can occur during the first, third, or fourth infection.

Key relevant resources

Dengue - the England National Travel Health Network and Centre (NaTHNaC): https://travelhealthpro.org.uk/disease/42/dengue#:~:text=The%20disease%20is%20transmitted%20through,usually%20a%20self-limiting%20illness.

List of the countries with risk of dengue:

https://www.cdc.gov/dengue/areas-with-risk/index.html

US Government Centers for Disease Control and Prevention Health's Yellow Book 2024 | Travelers' Health | Dengue: https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/dengue

Price per dose: £108
Age: 2 months+

Infanrix-IPV+Hib: INFANRIX-diphtheria tetanus pertussis (acellular), poliomyelitis and hib vaccine – Patient Information Leaflet (PIL) – (emc) (medicines.org.uk)

If a haemophilus influenzae type b (Hib) vaccine is required the Hib/MenC vaccine can be used:

Menitorix: Menitorix Powder and solvent for solution for injection – Patient Information Leaflet (PIL) – (emc) (medicines.org.uk)

Price Per Dose: £59
Number of Dor the Primary Course: 1
Minimum dose intervals: –
Age: 1+
When a booster dose is given (in years): 25 years after the 2nd dose*

*The UK Health Security Agency (UKHSA) 'Green Book' recommends a booster dose at 25 years for individuals at ongoing risk of hepatitis A, pending further evidence on the duration of protective immunity.

If I received one dose of the hepatitis A vaccine many years ago but did not complete the course, should I restart the entire vaccination process now?

No, there is no need to restart the entire course of vaccination; receiving one dose now will be sufficient to complete the course.

UK Guidance for Children:

Vaccination with the hepatitis A vaccine is recommended for individuals aged one year and older who are traveling to areas with high or medium levels of hepatitis A endemicity, or during outbreaks of the virus. The risk of disease is low for children under one year old, and vaccines are not approved for use in this age group. It is important to take precautions to avoid exposure to hepatitis A through contaminated food and water.

US Guidance for Children: 

If at risk, infants 6 to 11 months old should also be vaccinated against Hepatitis A. The dose does not count toward the routine 2-dose series.

For more information and vaccine schedules, please see here.

Price per dose: £55
Number of doses for primary course: 3 or 4
Minimum dose intervals: 0, 1, 6 months (3 dose schedule – if there is not enough time, 2 doses provide reasonable protection before travel) or rapid schedules: 0, 7, 21 days & 12 months (4 dose schedule).

Age: 16+
When a booster dose is given (in years): None is required routinely. 

After completing the full primary vaccination course for hepatitis B, a booster dose of the hepatitis B vaccine is not required. This guidance also applies to healthcare workers, with some exceptions.

Individuals not included are those with kidney failure, those who have experienced significant exposure, and healthcare or laboratory workers who did not respond to the primary vaccination course.

Reference: Hepatitis B: the green book, chapter 18 

When are rapid schedules used in preference to the standard schedule?

Rapid schedules are used instead of standard schedules for travellers who need maximum protection but lack time for the standard three-dose series.

Why do the rapid schedules have a 4th dose of vaccine?

The rapid vaccination schedule includes a fourth dose of the vaccine at 12 months to address the potential loss of initial protection provided by the first three doses. 

Now that the hepatitis B vaccine is included in the UK national vaccination schedule, does this mean we no longer need to vaccinate travelling children?
Children born on or after August 1, 2017, receive the hepatitis B vaccine and are protected after completing the vaccination course. However, children born before August 1, 2017, were not routinely given the hepatitis B vaccine and should be assessed for vaccination before travel or may require routine immunisation privately.

For more information and the vaccine schedules see here.

Price per dose: £180
Number of doses for primary course: 2 for 9-14 years & 3 for over 14
Minimum dose intervals: 0, 1, 4 months
Age: 9+ there is no upper age limit

When a booster dose is given (in years): Not required

See the vaccine insert here

Preventing HPV-related cancer with vaccination is much better than treating it!

Jan 2025

Price per dose: £20

We vaccinate children 6 months of age and over with flu injections.

For children, please call us to book an appointment. 

We offer NHS & Non-NHS flu vaccinations for ADULTS on Mondays, Tuesdays & Wednesdays.  

The private nasal flu vaccine is not available for the 2024-25 season.  However, we can vaccinate children 6 months + with the flu injections now. 

Influenza has been described as the most frequent vaccine-preventable infection among travellers to tropical and subtropical countries - see here for more information. 

Subject to stock availability

Price per Dose: £110
Number of Doses for Primary Course: 2
Minimum Dose Intervals:

• Standard schedule: 0 & 28 day
• Rapid schedule: 0 & 7 day 

Age Requirement: 2 month+
Booster Dose Timing (in years): 2 years for 1st booster and *10 years for 3rd booster

What are the benefits of the rapid schedule versus the normal day 0 and 28 day schedule?

The main benefit of the rapid schedule is that it can be used for those travellers leaving in less than one month. Ideally, both doses should be given at least one week prior to exposure to Japanese encephalitis.

*For more information and the vaccine schedules see here.

Price per dose: £135
Number of doses for primary course: 2
Minimum dose intervals: 1-2 months depends on the age
Age: 2 months+
When a booster dose given (in years): Not required

See the official vaccine insert here 

Price per dose: £70
Number of doses for primary course: 

Infants from 6 weeks to less than 6 months of age: two doses, each of 0.5 ml, should be administered with an interval of 2 months between doses.

Infants from 6 months of age, children, adolescents and adults: a single 0.5 mL dose should be administered.

Minimum dose intervals: See above.
Age: 6 weeks+ 
When a booster dose given (in years): 5 years for travel

The MenACWY vaccine we usually use is called Nimenrix.

Price per dose: £53
Number of doses for primary course: 2
Minimum dose intervals: 4 weeks
Age: 1+*
When a booster dose given (in years): Not required

Recommendations for measles vaccinations for travellers:

1. Infants (6 through 11 months old). One dose of a measles-containing vaccine should be given. This dose does not count as the first dose in the routine childhood vaccination series.
2. People 12 months old or older, without other presumptive evidence of measles immunity. Two appropriately spaced doses of a measles-containing vaccine should be given.
3. People 12 months old or older who have written documentation of one dose and no other presumptive evidence of measles immunity. One additional dose before travel.

There is now overwhelming evidence that MMR does not cause autism.

Also, it has been suggested that combined MMR vaccine could potentially overload the immune system. From the moment of birth, humans are exposed to countless numbers of infectious antigens and infectious agents in their everyday environment. Responding to the three viruses in MMR would use only a tiny proportion of the total capacity of an infant’s immune system. The three viruses in MMR replicate at different rates from each other and would be expected to reach high levels at different times (Green Book, chapter 21).

If the measles-containing vaccine is given to someone who turns out to be already immune either due to previous infection or previous vaccination, will it do any harm?

No. There are no ill effects from vaccinating such individuals as they will have pre-existing immunity that inhibits replication of the vaccine viruses.

Giving Yellow Fever and MMR vaccines:

A four-week minimum interval period should be observed between the administration of these two vaccines. Yellow Fever and MMR should not be administered on the same day.

Giving Chickenpox (varicella) and MMR vaccines:

If these vaccines are not administered on the same day, then a four-week minimum interval should be observed between vaccines.

Giving Tuberculin skin testing (Mantoux) and MMR vaccines:

If a tuberculin skin test has already been initiated, then MMR should be delayed until the skin test has been read unless protection against measles is required urgently. If a child has had a recent MMR and requires a tuberculin test, then a four-week interval should be observed.

Price per dose: £57
Number of doses for primary course: 1
Minimum dose intervals: –
Age: 2+

• Pneumococcal pneumonia is a potentially serious bacterial lung disease that can strike anytime without warning
• Don't confuse pneumococcal pneumonia with the flu
• Pneumococcal pneumonia can cause your lungs to fill with mucus, making it hard to breathe
• It can disrupt your life for weeks
• Symptoms can be severe

Pneumococcal polysaccharide vaccine (also known as Pneumovax 23 or PPSV23 or PPV23) is used by the NHS as a one-off vaccination for everybody 65 years of age and over OR those 2 years of age and over with specific chronic conditions, such as diabetes.

As a non-NHS service, we offer the following recommendations based on the latest CDC advice:

Pneumococcal conjugate vaccines are generally provide better and longer lasting protection than the PPSV23  (see here for more information).

PPSV23 is no longer recommended alone, however PPSV23 is recommended for adults after PCV13 or PCV15 vaccination (i.e. pneumococcal conjugate vaccines). PPSV23 is not recommended for people who have previously received a pneumococcal 20-valent conjugate vaccine (known as PCV20 or Apexxnar in the UK and Prevnar 20 in the US) vaccination.

CDC recommends PCV20 as an option for pneumococcal disease prevention in adults age 19 years or older who have not previously received a pneumococcal conjugate vaccine (those born prior to 2006 have not had a pneumococcal conjugate vaccine as part of their routine immunisation). 

If PCV20 is given, no further pneumococcal vaccination is recommended.

PCV20 is an option for adults 19 through 64 at increased risk for invasive pneumococcal disease due to behavioral or medical risk factors OR for adults age 65 or older.

See the official insert of the PPSV23 here

Price per dose: £106
Number of doses for primary course: 1
Minimum dose intervals: –
Age: 18+

• Pneumococcal pneumonia is a potentially serious bacterial lung disease that can strike anytime without warning
• Don't confuse pneumococcal pneumonia with the flu
• Pneumococcal pneumonia can cause your lungs to fill with mucus, making it hard to breathe
• It can disrupt your life for weeks
• Symptoms can be severe

Pneumococcal 20-valent conjugate vaccine (known as PCV20 or Apexxnar in the UK and Prevnar 20 in the US) helps protect against more strains of the bacteria that cause pneumococcal pneumonia than any other pneumococcal conjugate vaccine (i.e. PCV13 and PCV15).

Pneumococcal conjugate vaccines are generally provide better and longer lasting protection than the Pneumovax 23 (also known as Pneumovax 23 or PPSV23 or PV23) - see here for more information

Even if you’ve already been vaccinated with another pneumonia vaccine, PCV20 can help provide additional protection. 

Pneumococcal polysaccharide vaccine (Pneumovax 23) is used by the NHS as a one-off vaccination for everybody 65 years of age and over OR those 2 years of age and over with specific chronic conditions, such as diabetes.

As a non-NHS service, we offer the following recommendations based on the latest CDC advice:

• Pneumovax 23 is no longer recommended alone, however Pneumovax 23 is recommended for adults after PCV13 or PCV15 vaccination (i.e. pneumococcal conjugate vaccines).
• Pneumovax 23 is not recommended for people who have previously received a PCV20 vaccination.

CDC recommends PCV20 as an option for pneumococcal disease prevention in adults age 19 years or older who have not previously received a pneumococcal conjugate vaccine (those born prior to 2006 have not had a pneumococcal conjugate vaccine as part of their routine immunisation). 

If PCV20 is given, no further pneumococcal vaccination is recommended.

PCV20 is an option for adults 19 through 64 at increased risk for invasive pneumococcal disease due to behavioral or medical risk factors OR for adults age 65 or older.

See the official insert of the  PCV20 here

Intradermal (ID) injection: £55 per dose

We use the shorter schedule of 4 doses given in 2 appointments with a minimum 7-day interval (1 dose in both arms per visit), rather than the 3-dose schedule which requires 3 appointments over a minimum period of 21 days.

The above schedule has very recently been formalised in the UK (May 2024).

In most travel-related situations, this shorter schedule provides lifelong protection with no need for a booster dose.   From Verorab Package leaflet: Information for the user

Intramuscular (IM) injection: £110 per dose 

Minimum dose intervals: 

Conventional regimen: 0, 7, 21 days

Rapid Regimen (adults only – if not able to complete the conventional regimen): 0, 3, 7 & 365 days.

Age: Birth onward

Rabies is almost always fatal once symptoms appear. See here a very sad recent example: https://www.bbc.co.uk/news/uk-46180330 

Rabies cases are rare in travellers BUT animal bites and scratches are not, travellers should be aware of the risk and know what to do if they are bitten or scratched.

When is a booster dose given?

Routine booster doses are not recommended for most travellers. However, a single booster dose of vaccine can be considered following a risk assessment in those who have completed a primary course over one year ago and are travelling again to a high-risk (enzootic) area. A complete primary course is considered to be a three-dose pre-exposure immunisation course over 21-28 days or an accelerated three-dose course over 7 days plus an additional dose at one year or at the first opportunity after one year.

If you have rabies vaccine before travel does this mean that you don’t need any treatment if you get an animal bite while away?

No – they will still need treatment but this is much simpler and more as a precaution rather than an emergency. After the full course or pre-exposure rabies vaccine, a fully immunocompetent recipient should produce protective antibodies against rabies. Immediate first aid should be carried after any animal bite. In the event of an animal bite in a high or intermediate-risk area, this should be followed up with two further doses of rabies vaccine on days 0 and 3, to be given as quickly as possible after the animal bite. HRIG is not needed.

If a traveller is bitten by an animal, how would they know if the animal has rabies or not?

You cannot tell by looking at an animal whether it has rabies or not as symptoms are not always apparent. Although it is possible to determine whether an animal has rabies through laboratory testing (usually on a dead animal), for most travellers this is impossible.

Rabies, once symptoms develop, is always fatal, so every animal bite in a high risk area should be high-risks an emergency.

In countries where there is a low risk of animal rabies, travellers should still have any bite assessed quickly to ascertain if further action is required.

Remember, even in countries with no risk of animal rabies, bats may be infected.

How can I find out whether HRIG is available in the country my traveller is going to?

In most cases you can’t. HRIG is not I,n plentiful supply anywhere. Though it can be found when needed in most developed countries, in underdeveloped countries, including those with the highest risk of rabies, it will be very difficult or impossible to obtain HRIG.

It is worth noting that HRIG is produced from blood products, so even though this is essential for treatment for someone not previously vaccinated, it may pose a risk in itself in many countries.

What is the advice to travellers about monkey bites?

Travellers should be advised to never handle or feed monkeys. Should a traveller sustain a monkey bite or scratch then prompt first aid is important. Thorough irrigation is important and as with any infection, use of a chlorhexidine cothe containing soap or detergent will reduce the transmission of infection.

Post-exposure rabies treatment should be administered.

Tetanus vaccine +/- tetanus immunoglobulin should be given if the traveller is unvaccinated.

Antibiotic is usually advised.

Post-exposure prophylaxis for herpes B infection is unnecessary in travellers post-wild monkey bite, even from a rhesus macaque monkey. Good patient education with advice to seek prompt medical attention if they develop a blistering eruption at the site of the bite or develop a ‘flu-like’ illness within the 3-week post-bite is important to facilitate early diagnosis and treatment of any infection.

What is RSV?

• Respiratory syncytial virus (RSV) is a highly contagious virus that can easily spread by touching a contaminated surface. The virus can also spread if an infected person coughs or sneezes and their droplets contact another person's eyes, nose, or mouth.
• In the UK, RSV infections typically occur in the autumn and winter, and begin to offset in the spring.
• There is a substantial burden of RSV infection in older adults, which contributes to the seasonal winter pressures for the NHS.
• Unlike, COVID-19, there is no treatment for RSV, other than supportive care, for older adults.

NHS eligibility criteria for RSV vaccinations

1. The NHS will be vaccinating pregnant women (from 28 weeks) and older adults turning 75 on or after 1 September. There will also be a one-off ‘catch-up’ offer for everyone aged 75 to 79 years old.

However, currently RSV vaccines in the UK are authorised by MHRA for

1. adults 60 years of age and older;
2. adults 50 through 59 years of age who are at increased risk for RSV disease.

The US Centers for Disease Control and Prevention (CDC) recommended a single dose for:

• All adults 75 and older
• Adults 60 and older with certain chronic conditions like asthma, COPD, heart disease or severe diabetes

We provide private RSV vaccinations for individuals 50 and older, with no upper age limit.

• RSV vaccine can be given at the same time as other vaccines, such as influenza or COVID-19.
• One dose of adult RSV vaccine provides protection against RSV for at least 2 to 3 winter seasons, when RSV normally circulates. Additional data for both RSV vaccines are needed to determine how long the protection lasts.
• We usually stock both brands of RSV vaccines: Abrysvo (Pfizer) and Arexvy (GSK).

Arexvy (GSK): The Patient Information Leaflet (PIL)

Abrysvo (Pfizer): The Patient Information Leaflet (PIL)

Pfizer’s RSV vaccine, Abrysvo is available from us as a private vaccination.

This is the first and only RSV vaccine approved for pregnant women to help lower their babies’ risk of RSV from birth to 6 months.

Maternal immunisation refers to the process of vaccinating a pregnant woman so protective antibodies can be passed to the baby through the placenta before birth.

Get vaccinated after week 28 of your pregnancy, so you can pass RSV protection to your baby.  If possible, give two weeks interval between the whooping cough and RSV vaccinations.

This vaccine is fully authorised in the UK (see the official insert below). 

The NHS RSV vaccination programme cover pregnant women from Sep 2024 and only those 75 to 79 years of age, using the exact same vaccine we offer privately, i.e. Abrysvo for all those 60 years of age and above, as well as pregnant women.

Currently, there is no RSV vaccination available on the NHS for children.  However, we do offer this privately (i.e. Beyfortus, also known as nirsevimab).

Abrysvo (Pfizer): The Patient Information Leaflet (PIL)

Protect your child from RSV, which is the leading cause of hospitalisation in young children.

Respiratory syncytial virus (RSV) infects around 90% of infants and young children by the age of 2 and is a leading cause of hospitalisation in infants under 2 years in the UK.

Babies born prematurely or with health issues such as heart or lung problems are at even higher risk of becoming infected.

Beyfortus (nirsevimab) is a groundbreaking long-acting monoclonal antibody that reduces the risk of hospitalisation from RSV infection by almost 80%. 

Who should receive Beyfortus?

Beyfortus is recommended for:

• Newborns and babies under 1 year old entering their first RSV season
• Children up to 24 months old who remain at high risk of severe RSV during their second RSV season

It is particularly beneficial for:

• infants born to mothers who did not receive a maternal RSV vaccine 
• infants born less than 2 weeks after their mother received a maternal RSV vaccine
• infants born to mothers who were severely immunocompromised when they received a maternal RSV vaccine
• infants who have undergone procedures that reduce the antibodies they will receive if their mother has a maternal RSV vaccine
• infants and young children with certain risk conditions, regardless of whether their mother has had a maternal RSV vaccine.

Can Beyfortus be given at the same time as other vaccines?

Yes, Beyfortus can be administered on the same day as routine childhood vaccines, including influenza.  There is no need to wait between administering Beyfortus and live vaccines such as MMR or chickenpox.

How do we access Beyfortus?

• We import Beyfortus with authorisation from the UK medicines regulator (MHRA).  Because this is a pharmaceutical that is not supplied directly in the UK by the manufacturer (Sanofi)
• We work with a trusted UK pharmaceutical importer to ensure quality and safety.

Cost & Ordering:

The cost of Beyfortus is £1,450.00, including medication and administration.

To book an appointment, please email us the following information:

1. Your child's full name
2. Your child's date of birth
3. Your mobile number
4. Your child's weight 

We will then contact you to arrange payment and schedule your appointment.

Important Notes:

• We require full payment in advance.
• We offer a full refund if we cannot administer Beyfortus to your child. However, if you order Beyfortus and then change your mind, we cannot provide a refund.
• Lead time: Approx. 7 days  
• We can immunise children weighing under and over 5 kg.

Learn more:

• UK official product information
• US official Beyfortus website
• Australian recommendations 

Contact us today to protect your child from RSV: info@hhpharmacy.co.uk

Estimated annual age-specific incidence of shingles per 100,000 per year in the immunocompetent population in England and Wales (population 2007). Data taken from van Hoek et al., 2009.

Estimated percentage developing Post Herpetic Neuralgia (PHN) by age group in the immunocompetent population in England and Wales (population 2007). Data taken from van Hoek et al., 2009.

Ref: The Green Book, Feb 2019

We also offer vaccinations with the new non-live shingles vaccine (£230 per dose inclusive – 2x doses required 2-6 months apart).

For more information, please see our shingles vaccination page here.

Price per dose: £460 for the full course inclusive (the new non-live shingles vaccine)
Number of doses for primary course: 2
Minimum dose intervals: 2
Age: 18+
When a booster dose given (in years): Not required

Prices: £35

Circadian rhythms regulate our sleep patterns and need time to adjust to changes in local time (usually about one day per time zone crossed). Westward travel may be better tolerated than eastward travel but problems occur when travelling in both directions. The effects of jet lag include – sleep disturbance, loss of appetite, nausea and sometimes vomiting, bowel changes (e.g. constipation), general malaise, tiredness and poor concentration.

After arrival hypnotics (sleeping tablets) have been shown to help with jet lag.

Notes: For more info visit: https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/jet-lag

Price per dose: £70 

Age: 1 year+

Ticks can transmit Lyme disease, which is treatable with antibiotics. In contrast, there is no specific treatment for TBE.

To help protect against TBE, vaccination should be considered for all at-risk travelers.

See the TBE vaccine's dosing schedule here.

Price per dose: £44
Number of doses for primary course: 3
Minimum dose intervals: –
Age: 

• 2+ for the injection*
• 5+ for the oral capsule

When a booster dose given (in years): 3

The UK Health Security Agency’s Green Book, specifically Chapter 33 on Typhoid, recommends that children aged 12 months to 2 years should receive the injectable typhoid vaccine if they are traveling to areas where the risk of typhoid is high. This is particularly advised for those visiting friends and family in Southeast Asia for four weeks or more.

For more information and the vaccine schedules see here.

Price per dose: £100
Number of doses for primary course: 1
Minimum dose intervals: –
Age: 3+
When a booster dose given (in years): Not required

Usually required for US visa clearance or visiting a newborn 

There are two options:  

Repevax is a 4 in 1 vaccine which contains: Diphtheria, Tetanus, Pertussis (acellular) and Poliomyelitis (inactivated).  See the vaccine official insert here. 

Adacel is a 3 in 1 vaccine which contains: Diphtheria, Tetanus, Pertussis.  See the vaccine official insert here. 

There have been large outbreaks of pertussis (whooping cough) recently, affecting several countries in recent years. This includes the UK, Australia, Canada and USA. Duration of protection from pertussis vaccine, or from having had the disease, is relatively short-lived. It is unlikely to be more than 10 years and may be less.

In some countries, an approach known as ‘cocooning’ is used. This involves vaccinating all those in close contact with the baby – for example partners, spouses, immediate family and grandparents.

Price per dose: £75
Number of doses for primary course: 1
Minimum dose intervals: –
Age: 9 month+
When a booster dose given (in years): Not required

Do I need a certificate if my flight transits through a country with risk of yellow fever transmission?

Check individual country recommendations for up to date advice. It should be noted that some countries require proof of vaccination from all travellers.

A four week minimum interval period should be observed between the administration of these two vaccines. Yellow Fever and MMR should not be administered on the same day.

For more information and the vaccine schedules see here.

Price per dose: £35
Number of doses for primary course: –
Minimum dose intervals: –
Age: –
When a booster dose given (in years): –

We issue medical letter of exemption from the requirement for an International Certificate of Vaccination or Prophylaxis (ICVP) when appropriate / required – See here for more information: https://nathnacyfzone.org.uk/factsheet/6/medical-letter-of-exemption

Can a lost certificate be reissued?

Re-issuing a certificate is permissible if you have records of the dates and batch numbers from when the vaccine was administered. If not, then the only legally acceptable approach to satisfy immigration authorities is to repeat the vaccination.